XORTX Therapeutics XRTX Ratios (2020-2026)

NASDAQ XRTX
$2.00 -0.05 (-2.44%)
At close: Aug 19, 2026 · 4:00 PM EDT
Ratios Dec2020 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -73.97%-100.00%-140.09%
EBIT Margin (Quarter) -73.97%-100.00%-140.09%
EBITDA Margin (Quarter) -73.97%-100.00%-140.09%
Net Margin (Quarter) -73.97%-100.00%-140.09%
FCF Margin (Quarter) 0.15%0.13%
Efficiency
Assets Average (Quarter) 11.85M16.02M13.57M12.03M11.91M11.00M8.73M7.22M5.42M4.32M3.97M3.80M3.12M2.78M2.75M2.41M
Invested Capital (Quarter) 0.79M0.56M
Asset Utilization Ratio (Quarter) 0.831.040.970.710.70
Leverage & Solvency
Interest Coverage Ratio (Quarter) -14.59
Times Interest Earned (Quarter) -14.59
Valuation
Enterprise Value (Quarter) -0.13M-3.97M-14.96M-12.24M-10.53M-9.32M-10.41M-5.07M-3.84M-3.08M-2.30M-2.47M-1.90M-1.06M-1.19M-0.86M-0.25M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%-0.01%
Return on Capital Employed (Quarter) -17.68%-13.31%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%-0.01%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.03%-0.03%